Although the biological function of CD133 remains unknown, it has been suggested to participate in primitive cell differentiation and epithelial–mesenchymal interactions, autophagy, and, thus, in the malignant progression of ovarian cancer [132]. Here, PROM1 is linked to ovarian carcinoma.